Become a Member

Track your favourite stocks
Create & monitor portfolios
Daily portfolio value

Company	Chg	Chg %
Quickpicks
£	%
Add shares to your quickpicks to display them here!

Form 8.3 - The Vanguard Group, Inc.: UDG Healthcare plc

20th Jul 2021 14:22

The Vanguard Group, Inc. ( IRSH) Form 8.3 - The Vanguard Group, Inc.: UDG Healthcare plc 20-Jul-2021 / 14:21 GMT/BST Dissemination of a Regulatory Announcement, transmitted by EQS Group. The issuer is solely responsible for the content of this announcement.

Ap19

FORM 8.3

IRISH TAKEOVER PANEL

DISCLOSURE UNDER RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER RULES, 2013

DEALINGS BY PERSONS WITH IN INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE

1. KEY INFORMATION

Name of person dealing (Note 1)	The Vanguard Group, Inc.
Company dealt in	UDG Healthcare plc
Class of relevant security to which the dealings being disclosed relate (Note 2)	€0.05 Ordinary Shares
Date of dealing	16 July 2021

2. INTERESTS AND SHORT POSITIONS

(a) Interests and short positions (following dealing) in the class of relevant security dealt in (Note 3)

	Long		Short
	Numbers	(%)	Numbers	(%)
(1) Relevant securities	11,340,065	4.50%
(2) Derivatives (other than options)
(3) Options and agreements to purchase/sell
Total	11,340,065	4.50%

(b) Interests and short positions in relevant securities of the company, other than the class dealt in (Note 3)

Class of relevant security:	Long		Short
	Numbers	(%)	Numbers	(%)
(1) Relevant securities
(2) Derivatives (other than options)
(3) Options and agreements to purchase/sell
Total

Ap20

1. Dealings (Note 4)

(a) Purchases and sales

Purchase/sale	Number of relevant securities	Price per unit (Note 5)
Sale	2,148	10.72 GBP

(b) Derivatives transactions (other than options transactions)

Product name,

e.g. CFD

Nature of transaction

(Note 6)

Number of relevant securities

(Note 7)

Price per unit

(Note 5)

Not Applicable

(i) Writing, selling, purchasing or varying

Product name,

e.g. call option

Writing, selling, purchasing, varying etc.

Number of securities to which the option relates (Note 7)

Exercise price

Type, e.g. American, European etc.

Expiry date

Option money paid/received per unit (Note 5)

Not Applicable

(ii) Exercising

Product name,

e.g. call option

Number of securities

Exercise price per unit (Note 5)

Not Applicable

(e) Other dealings (including transactions in respect of new securities) (Note 4)

Nature of transaction

(Note 8)

Details

Price per unit

(if applicable) (Note 5)

Not Applicable

Ap21

2. OTHER INFORMATION

Agreements, arrangements or understandings relating to options or derivatives

Full details of any agreement, arrangement or understanding between the person disclosing and any other person relating to the voting rights of any relevant securities under any option referred to on this form or relating to the voting rights or future acquisition or disposal of any relevant securities to which any derivative referred to on this form is referenced. If none, this should be stated.

Is a Supplemental Form 8 attached? (Note 9) NO

Date of disclosure	20 July 2021
Contact name	Shawn Acker
Telephone number	001-610-669-8989
If a connected EFM, name of offeree/offeror with which connected
If a connected EFM, state nature of connection (Note 10)


Category Code:	RET - UDG Healthcare plc
TIDM:	IRSH
LEI Code:	5493002789CX3L0CJP65
Sequence No.:	118060
EQS News ID:	1220363


End of Announcement	EQS News Service

UK Regulatory announcement transmitted by DGAP - a service of EQS Group AG. The issuer is solely responsible for the content of this announcement.

Related Shares:

FTSE 100 Latest

Value8,809.74

Change53.53